Biophysics and Biochemistry of Macromolecular Interactions Laboratory
Hospital Miguel Servet
Zaragoza, EspañaHospital Miguel Servet -ko ikertzaileekin lankidetzan egindako argitalpenak (13)
2024
-
APOE and familial hypercholesterolemia
Current Opinion in Lipidology, Vol. 35, Núm. 4, pp. 195-199
-
OptiMo-LDLr: An Integrated In Silico Model with Enhanced Predictive Power for LDL Receptor Variants, Unraveling Hot Spot Pathogenic Residues
Advanced Science, Vol. 11, Núm. 13
2023
-
Contribution of APOE Genetic Variants to Dyslipidemia
Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 43, Núm. 6, pp. 1066-1077
2022
-
Leu22_Leu23 Duplication at the Signal Peptide of PCSK9 Promotes Intracellular Degradation of LDLr and Autosomal Dominant Hypercholesterolemia
Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 42, Núm. 7, pp. E203-E216
-
Lipoprotein(a) in hereditary hypercholesterolemia: Influence of the genetic cause, defective gene and type of mutation
Atherosclerosis, Vol. 349, pp. 211-218
2021
-
Diagnostic yield of sequencing familial hypercholesterolemia genes in individuals with primary hypercholesterolemia
Revista Espanola de Cardiologia, Vol. 74, Núm. 8, pp. 664-673
-
MLb-LDLr: A Machine Learning Model for Predicting the Pathogenicity of LDLr Missense Variants
JACC: Basic to Translational Science, Vol. 6, Núm. 11, pp. 815-827
2020
-
Predicted pathogenic mutations in STAP1 are not associated with clinically defined familial hypercholesterolemia
Atherosclerosis, Vol. 292, pp. 143-151
2019
-
Lipid-lowering response in subjects with the p.(Leu167del) mutation in the APOE gene
Atherosclerosis, Vol. 282, pp. 143-147
-
The Arg499His gain-of-function mutation in the C-terminal domain of PCSK9
Atherosclerosis, Vol. 289, pp. 162-172
2018
2016
-
The p.Leu167del mutation in APOE gene causes autosomal dominant hypercholesterolemia by down-regulation of LDL receptor expression in hepatocytes
Journal of Clinical Endocrinology and Metabolism, Vol. 101, Núm. 5, pp. 2113-2121
2015
-
Functional characterization and classification of frequent low-density lipoprotein receptor variants
Human Mutation, Vol. 36, Núm. 1, pp. 129-141